What Wegovy Does to Your Mouth: Dry Mouth, Taste Changes and Ulcers

Dry mouth and altered taste are recognised side effects linked to how semaglutide reduces appetite and slows gastric emptying.
Most mouth-related effects are mild to moderate and tend to ease as your body adjusts to the medicine, particularly after the first few weeks on a new dose.
Mouth ulcers are less common but have been reported; dehydration from nausea or vomiting can make them more likely.
Staying well hydrated and eating slowly matters more on GLP-1 treatment than it did before, and both help protect your mouth.

Semaglutide (Wegovy) can affect the mouth in several ways, including dryness, altered taste and occasional ulcers. These effects are real, documented in clinical data, and worth understanding before you start treatment. They are not a sign something has gone badly wrong, but they do deserve a clear explanation. As a prescription-only medicine, Wegovy is available only after a clinical assessment confirms it is right for you personally.

Starting from £29.99/mo

Free 2-minute consultation · Reviewed same day

Start journey
The nume Promise

Order by 12pm.

At your door the next working day.
Free, tracked, plain packaging.

Guaranteed on approved orders

Where are you starting from?

BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.

Check your BMI.

Ten seconds. Private — nothing is stored or shared.

80 kg
170 cm

Your result updates live in the card alongside.

Your result

Your BMI is

which is in the healthy weight range

Start journey

BMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.

Treatment options

Weight loss treatments

The problem

Most weight loss services treat you like a transaction, a checkout, a courier, and you're on your own.

Algorithm approvalsNo real clinicianGeneric dosingHidden feesSlow deliverySilence after checkout

The nume way

We built the opposite: one clinician who knows you, guaranteed care at every step.

24 hrs

clinician review. Free next working day delivery.

How it works

From consultation to your door, properly.

Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.

Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.

Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.

What the evidence says, and what you can do about it day to day

What the STEP 1 trial and the Wegovy patient information tell us about mouth effects

The STEP 1 phase-3 trial, published in the New England Journal of Medicine, enrolled nearly 2,000 adults with obesity and tracked them for 68 weeks on semaglutide 2.4mg. The most frequently reported side effects were gastrointestinal: nausea, diarrhoea, vomiting and constipation accounted for the vast majority of adverse events. Mouth-specific symptoms were not among the headline findings, but they sit within a broader pattern: when the gut slows down and saliva production is disrupted by reduced food intake and frequent nausea, the mouth bears some of the consequences.

The NHS medicines page for semaglutide lists dry mouth as an uncommon side effect — meaning it affects fewer than 1 in 10 people but more than 1 in 100. That places it in the same category as burping and heartburn: not unusual enough to be remarkable, not common enough to be guaranteed. If you search online for whether Wegovy causes dry mouth, you will find plenty of people who have experienced it; the frequency just tends to be under-reported in official summaries because it is rarely severe.

Taste changes follow a similar pattern. Semaglutide alters appetite signalling in the brain and slows the rate at which food moves through the stomach. Both of these changes can dull or shift how flavours register. Some people find sweet foods taste less appealing; others notice a metallic or slightly bitter background. The effect is usually partial and temporary, though it may last for several weeks after a dose increase.

Why dry mouth happens on Wegovy, and what actually helps

Saliva production is partly governed by eating behaviour. When Wegovy reduces hunger and you eat smaller, less frequent meals, less chewing and less food stimulation means less saliva. Nausea compounds this: if you are sipping rather than drinking freely to avoid triggering sickness, mild dehydration sets in, and the mouth dries out. That is the mechanism behind most cases of Wegovy-related dry mouth.

The practical fixes are straightforward, if not always easy to maintain. Sipping plain water consistently across the day helps more than drinking large amounts in one go. Sugar-free chewing gum stimulates saliva without adding anything that would irritate an already-sensitive stomach. Alcohol and caffeine both worsen dehydration, so cutting back during dose-increase weeks is worth trying. Breathing through the nose rather than the mouth sounds simple, but mouth-breathing accelerates drying.

It is worth knowing that dry mouth linked to Wegovy rarely requires stopping treatment. In most cases, the symptom peaks in the first two to four weeks on a new dose and then settles. If it persists or feels severe, it should be raised with your prescriber at the next check-in, not managed in silence.

For context on what the wider treatment involves, including how doses are structured and what clinical monitoring looks like, the Wegovy overview on this site covers the full picture.

Mouth ulcers and taste problems: how common, and when to act

A Wegovy mouth ulcer is less common than dry mouth but follows recognisable logic. Dehydration dries the mucosal lining; minor abrasions from food heal more slowly when saliva is scarce; and stress on the immune system during early treatment can temporarily reduce resistance to the kind of minor infections that produce ulcers. None of that means Wegovy is causing tissue damage. It means conditions in the mouth become slightly less favourable for a period.

A persistent bad or metallic taste is reported less often than dryness, but it does appear in patient accounts and is consistent with the altered digestive rhythm. Gastric acid that lingers longer in the oesophagus (a recognised GLP-1 class effect) can contribute a sour or bitter note. Gentle antacids, eating smaller amounts more slowly, and avoiding lying flat for at least an hour after eating all reduce reflux and, with it, the taste disruption.

If mouth ulcers are large, fail to heal within two weeks, appear repeatedly, or are accompanied by fever, see your GP or dentist. That advice applies regardless of whether you are on Wegovy; it is the standard threshold for investigating a mouth ulcer. For everything below that threshold, standard over-the-counter gels and good hydration are appropriate first steps, and your prescriber should know about it at your next review.

How semaglutide treatment fits into the broader picture of weight management

Mouth symptoms, when they do arise, are one small part of a treatment that the STEP 1 trial showed to reduce body weight by around 15% on average over 68 weeks in people with obesity. For most people, the side-effect profile is manageable; the gastrointestinal effects, including those that touch the mouth, typically ease over time. The licensed route to Wegovy in the UK is a prescription from a qualified prescriber, following an assessment of your health history and current circumstances. There is no shortcut around that step, and nor should there be.

If you are trying to understand whether Wegovy is right for you, the semaglutide information page gives a grounded, clinically accurate overview. For those weighing up different treatment options (including the range of licensed weight-loss treatments available in the UK) a full consultation is the right place to start. You can also read more about how our clinical team approaches prescribing on the prescriber profile page. Questions about cost? That sits on a separate page; you can find what to expect when accessing Wegovy privately there. When you are ready to take the next step, start your free consultation and a GPhC-registered prescriber, not an algorithm, will review your answers the same day.

Looking to start your weight loss journey?
Take a quick eligibility quiz to explore your options and see how we can support you.
Start free consultation

The people

Meet the team.

Mahommed Zunaid Ayub Patel

Superintendent Pharmacist (GPhC No. 2217101)

Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.

Mostafa Damghani

Clinical Lead (GPhC No. 2231744)

Sets our clinical standards and checks everything we publish against current MHRA guidance.

Shelan Salih

Independent Prescriber (GPhC No. 2084501)

Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.

Rehenaaz Uddin

Independent Prescriber (GPhC No. 2083426)

Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.

Frequently asked questions